Canisius Wilhelmina Hospital
Nijmegen, Gelderland, 6532SZ, Netherlands
NCT Number: NCT03572413
Substudy of the RECOVER trial (a randomised controlled trial comparing the effect of low pressure pneumoperitoneum with deep neuromuscular block versus normal pressure pneumoperitoneum with moderate neuromuscular block during laparoscopic colorectal surgery on early quality of recovery) investigating innate immune homeostasis after laparoscopic colorectal surgery.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Nijmegen, Gelderland, 6532SZ, Netherlands
Rationale: increased intra-abdominal pressure can cause peritoneal mesothelial cell injury either directly or by compression of the capillary vessels, causing a variable degree of ischemia reperfusion injury. The immune system can identify damage to host cells by recognising Danger-Associated Molecular Patterns (DAMPs) that are released upon cell death in an uncontrolled fashion, such as during surgical trauma. DAMPs elicit an immune response similar to the response to invading pathogens and induce an anti-inflammatory immune response strongly related to postoperative recovery, infectious complications and mortality. Low pressure PNP is associated with lower levels of serum pro- and anti-inflammatory cytokines and better preservation of innate immune function.
Objective: to establish the relationship between the use of low pressure pneumoperitoneum with deep neuromuscular blockade and innate immune function after laparoscopic colorectal surgery.
Study design: a multi-center, blinded, randomized controlled clinical trial.
Study population: adult individuals scheduled for laparoscopic colorectal surgery with a primary colonic anastomosis.
Intervention: participants will be randomly assigned in a 1:1 fashion to either the experimental group (group A): low pressure PNP (8 mmHg) with deep NMB (PTC 1-2) or the control group (group B): normal pressure PNP (12 mmHg) with moderate NMB (TOF count 1-2).
Primary endpoint: mononuclear cell responsiveness ex-vivo as reflected by TNFα release upon LPS stimulation.
Secondary endpoints: mononuclear cell responsiveness ex-vivo as reflected by IL-6, IL-10 and IL-1beta release upon LPS stimulation. Peritoneal mesothelial hypoxia as reflected by peritoneal HIF1α mRNA expression, histological peritoneal mesothelial cell injury and plasma levels of DAMPs and cytokines.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Lowering intra-abdominal pressure during laparoscopic surgery
Other names: Low intra-abdominal pressure
Deep (PTC 1-2) versus moderate (TOF count 1-2) neuromuscular block
Other names: Deep muscle relaxation
Time frame: Before surgery, 24 and 72 hours after surgery
TNFalpha release upon LPS stimulation
Time frame: Before surgery, 24 and 72 hours after surgery
IL-6, IL-10 and IL-1beta release upon LPS stimulation
Time frame: Before surgery, at the end of surgery and 24 hours after surgery
Danger associated molecular patterns, TNFalpha, IL-6 and IL-10
Time frame: Before surgery, 24 and 72 hours after surgery
MHC-II antigen presenting immune receptor
Time frame: At the start and end of surgery
Histology and HIF1alpha mRNA expression of a peritoneal biopsy
Radboud University Medical Center
Other
The Effectiveness of Low Pressure Pneumoperitoneum During Laparoscopic Colorectal Surgery in Preserving Innate Immune Homeostasis by Reducing Peritoneal Mesothelial Cell Injury.
Acronym: RECOVER-PLUS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03608436
Digestive System Diseases, Neuromuscular Blockade
Nijmegen, Gelderland, Netherlands
View Trial DetailsNCT04468698
Digestive System Diseases, Intra Abdominal Pressure
Valencia, Spain
View Trial DetailsNCT02079337
Digestive System Diseases, Laparoscopy
Søborg, Denmark
View Trial DetailsNCT07438132
Digestive System Diseases, Laparoscopic Surgery
Taipei, Taiwan
View Trial Details